nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Fluorouracil—head and neck cancer	0.427	0.747	CbGbCtD
Letrozole—CYP3A4—Vinblastine—head and neck cancer	0.0791	0.138	CbGbCtD
Letrozole—CYP3A4—Docetaxel—head and neck cancer	0.0652	0.114	CbGbCtD
Letrozole—Cancer pain—Docetaxel—head and neck cancer	0.0337	0.0809	CcSEcCtD
Letrozole—Edema of lower extremities—Docetaxel—head and neck cancer	0.0121	0.029	CcSEcCtD
Letrozole—Lymphoedema—Docetaxel—head and neck cancer	0.00994	0.0239	CcSEcCtD
Letrozole—Thromboembolic event—Docetaxel—head and neck cancer	0.00901	0.0216	CcSEcCtD
Letrozole—Dysaesthesia—Fluorouracil—head and neck cancer	0.00777	0.0187	CcSEcCtD
Letrozole—Dysaesthesia—Docetaxel—head and neck cancer	0.00561	0.0135	CcSEcCtD
Letrozole—Bone pain—Vinblastine—head and neck cancer	0.00535	0.0128	CcSEcCtD
Letrozole—Neoplasm—Vinblastine—head and neck cancer	0.00463	0.0111	CcSEcCtD
Letrozole—Phlebitis—Vinblastine—head and neck cancer	0.00431	0.0104	CcSEcCtD
Letrozole—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00424	0.0102	CcSEcCtD
Letrozole—Neoplasm—Hydroxyurea—head and neck cancer	0.00422	0.0101	CcSEcCtD
Letrozole—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00418	0.01	CcSEcCtD
Letrozole—Polyp—Docetaxel—head and neck cancer	0.00399	0.00958	CcSEcCtD
Letrozole—Eye irritation—Fluorouracil—head and neck cancer	0.00394	0.00946	CcSEcCtD
Letrozole—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00379	0.00911	CcSEcCtD
Letrozole—Embolism—Docetaxel—head and neck cancer	0.00378	0.00908	CcSEcCtD
Letrozole—Cyst—Docetaxel—head and neck cancer	0.00363	0.00872	CcSEcCtD
Letrozole—Rash erythematous—Docetaxel—head and neck cancer	0.00317	0.00761	CcSEcCtD
Letrozole—Pleural effusion—Docetaxel—head and neck cancer	0.00317	0.00761	CcSEcCtD
Letrozole—Angina pectoris—Vinblastine—head and neck cancer	0.00313	0.00752	CcSEcCtD
Letrozole—Breast disorder—Hydroxyurea—head and neck cancer	0.00306	0.00736	CcSEcCtD
Letrozole—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00306	0.00734	CcSEcCtD
Letrozole—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00302	0.00725	CcSEcCtD
Letrozole—Depression—Vinblastine—head and neck cancer	0.00286	0.00686	CcSEcCtD
Letrozole—Eye irritation—Docetaxel—head and neck cancer	0.00284	0.00683	CcSEcCtD
Letrozole—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00282	0.00678	CcSEcCtD
Letrozole—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00282	0.00677	CcSEcCtD
Letrozole—Myocardial infarction—Vinblastine—head and neck cancer	0.00281	0.00675	CcSEcCtD
Letrozole—Bone disorder—Docetaxel—head and neck cancer	0.00269	0.00645	CcSEcCtD
Letrozole—Weight increased—Hydroxyurea—head and neck cancer	0.00267	0.00641	CcSEcCtD
Letrozole—Infestation—Hydroxyurea—head and neck cancer	0.00261	0.00628	CcSEcCtD
Letrozole—Infestation NOS—Hydroxyurea—head and neck cancer	0.00261	0.00628	CcSEcCtD
Letrozole—Haemoglobin—Vinblastine—head and neck cancer	0.00258	0.00621	CcSEcCtD
Letrozole—Haemorrhage—Vinblastine—head and neck cancer	0.00257	0.00618	CcSEcCtD
Letrozole—Hypoaesthesia—Vinblastine—head and neck cancer	0.00256	0.00615	CcSEcCtD
Letrozole—Stomatitis—Hydroxyurea—head and neck cancer	0.00255	0.00612	CcSEcCtD
Letrozole—Bone pain—Docetaxel—head and neck cancer	0.00253	0.00608	CcSEcCtD
Letrozole—Cardiac failure—Fluorouracil—head and neck cancer	0.0025	0.00601	CcSEcCtD
Letrozole—Lethargy—Fluorouracil—head and neck cancer	0.00249	0.00598	CcSEcCtD
Letrozole—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00247	0.00593	CcSEcCtD
Letrozole—Pulmonary embolism—Docetaxel—head and neck cancer	0.00243	0.00583	CcSEcCtD
Letrozole—Haemoglobin—Hydroxyurea—head and neck cancer	0.00236	0.00566	CcSEcCtD
Letrozole—Haemorrhage—Hydroxyurea—head and neck cancer	0.00235	0.00563	CcSEcCtD
Letrozole—Irritability—Fluorouracil—head and neck cancer	0.00233	0.00559	CcSEcCtD
Letrozole—Alopecia—Vinblastine—head and neck cancer	0.00227	0.00546	CcSEcCtD
Letrozole—Dry skin—Fluorouracil—head and neck cancer	0.00224	0.00537	CcSEcCtD
Letrozole—Neoplasm—Docetaxel—head and neck cancer	0.00219	0.00527	CcSEcCtD
Letrozole—Lightheadedness—Docetaxel—head and neck cancer	0.00217	0.00521	CcSEcCtD
Letrozole—Angiopathy—Hydroxyurea—head and neck cancer	0.00213	0.00511	CcSEcCtD
Letrozole—Ill-defined disorder—Vinblastine—head and neck cancer	0.00208	0.00499	CcSEcCtD
Letrozole—Alopecia—Hydroxyurea—head and neck cancer	0.00207	0.00498	CcSEcCtD
Letrozole—Angina pectoris—Fluorouracil—head and neck cancer	0.00205	0.00493	CcSEcCtD
Letrozole—Phlebitis—Docetaxel—head and neck cancer	0.00204	0.00491	CcSEcCtD
Letrozole—Thrombophlebitis—Docetaxel—head and neck cancer	0.00203	0.00489	CcSEcCtD
Letrozole—Malaise—Vinblastine—head and neck cancer	0.00202	0.00485	CcSEcCtD
Letrozole—Vertigo—Vinblastine—head and neck cancer	0.00201	0.00483	CcSEcCtD
Letrozole—Leukopenia—Vinblastine—head and neck cancer	0.002	0.00481	CcSEcCtD
Letrozole—Hypertension—Vinblastine—head and neck cancer	0.00193	0.00464	CcSEcCtD
Letrozole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00189	0.00455	CcSEcCtD
Letrozole—Discomfort—Vinblastine—head and neck cancer	0.00188	0.00452	CcSEcCtD
Letrozole—Hot flush—Docetaxel—head and neck cancer	0.00188	0.00452	CcSEcCtD
Letrozole—Infestation—Fluorouracil—head and neck cancer	0.00188	0.00452	CcSEcCtD
Letrozole—Infestation NOS—Fluorouracil—head and neck cancer	0.00188	0.00452	CcSEcCtD
Letrozole—Menopausal symptoms—Docetaxel—head and neck cancer	0.00187	0.00448	CcSEcCtD
Letrozole—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00185	0.00445	CcSEcCtD
Letrozole—Myocardial infarction—Fluorouracil—head and neck cancer	0.00184	0.00443	CcSEcCtD
Letrozole—Malaise—Hydroxyurea—head and neck cancer	0.00184	0.00442	CcSEcCtD
Letrozole—Stomatitis—Fluorouracil—head and neck cancer	0.00183	0.0044	CcSEcCtD
Letrozole—Urinary tract infection—Fluorouracil—head and neck cancer	0.00183	0.00439	CcSEcCtD
Letrozole—Leukopenia—Hydroxyurea—head and neck cancer	0.00183	0.00439	CcSEcCtD
Letrozole—Cardiac failure—Docetaxel—head and neck cancer	0.0018	0.00433	CcSEcCtD
Letrozole—Lethargy—Docetaxel—head and neck cancer	0.0018	0.00432	CcSEcCtD
Letrozole—Pain in extremity—Docetaxel—head and neck cancer	0.00176	0.00423	CcSEcCtD
Letrozole—Anorexia—Vinblastine—head and neck cancer	0.00174	0.00418	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00173	0.00415	CcSEcCtD
Letrozole—Discomfort—Hydroxyurea—head and neck cancer	0.00172	0.00413	CcSEcCtD
Letrozole—Haemoglobin—Fluorouracil—head and neck cancer	0.0017	0.00408	CcSEcCtD
Letrozole—Haemorrhage—Fluorouracil—head and neck cancer	0.00169	0.00405	CcSEcCtD
Letrozole—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00168	0.00403	CcSEcCtD
Letrozole—Oedema—Hydroxyurea—head and neck cancer	0.00167	0.004	CcSEcCtD
Letrozole—Infection—Hydroxyurea—head and neck cancer	0.00166	0.00398	CcSEcCtD
Letrozole—Paraesthesia—Vinblastine—head and neck cancer	0.00164	0.00394	CcSEcCtD
Letrozole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00163	0.00392	CcSEcCtD
Letrozole—Skin disorder—Hydroxyurea—head and neck cancer	0.00162	0.00389	CcSEcCtD
Letrozole—Dry skin—Docetaxel—head and neck cancer	0.00161	0.00388	CcSEcCtD
Letrozole—Breast disorder—Docetaxel—head and neck cancer	0.00159	0.00382	CcSEcCtD
Letrozole—Anorexia—Hydroxyurea—head and neck cancer	0.00159	0.00382	CcSEcCtD
Letrozole—Decreased appetite—Vinblastine—head and neck cancer	0.00159	0.00382	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00159	0.00381	CcSEcCtD
Letrozole—Constipation—Vinblastine—head and neck cancer	0.00156	0.00375	CcSEcCtD
Letrozole—Pain—Vinblastine—head and neck cancer	0.00156	0.00375	CcSEcCtD
Letrozole—Feeling abnormal—Vinblastine—head and neck cancer	0.00151	0.00362	CcSEcCtD
Letrozole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00149	0.00359	CcSEcCtD
Letrozole—Alopecia—Fluorouracil—head and neck cancer	0.00149	0.00358	CcSEcCtD
Letrozole—Dyspnoea—Hydroxyurea—head and neck cancer	0.00149	0.00357	CcSEcCtD
Letrozole—Angina pectoris—Docetaxel—head and neck cancer	0.00148	0.00356	CcSEcCtD
Letrozole—Somnolence—Hydroxyurea—head and neck cancer	0.00148	0.00356	CcSEcCtD
Letrozole—Dyspepsia—Hydroxyurea—head and neck cancer	0.00147	0.00352	CcSEcCtD
Letrozole—Decreased appetite—Hydroxyurea—head and neck cancer	0.00145	0.00348	CcSEcCtD
Letrozole—Abdominal pain—Vinblastine—head and neck cancer	0.00144	0.00347	CcSEcCtD
Letrozole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00144	0.00346	CcSEcCtD
Letrozole—Fatigue—Hydroxyurea—head and neck cancer	0.00144	0.00345	CcSEcCtD
Letrozole—Constipation—Hydroxyurea—head and neck cancer	0.00142	0.00342	CcSEcCtD
Letrozole—Pain—Hydroxyurea—head and neck cancer	0.00142	0.00342	CcSEcCtD
Letrozole—Weight increased—Docetaxel—head and neck cancer	0.00139	0.00333	CcSEcCtD
Letrozole—Vision blurred—Fluorouracil—head and neck cancer	0.00138	0.00333	CcSEcCtD
Letrozole—Weight decreased—Docetaxel—head and neck cancer	0.00138	0.00331	CcSEcCtD
Letrozole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00137	0.0033	CcSEcCtD
Letrozole—Infestation NOS—Docetaxel—head and neck cancer	0.00136	0.00326	CcSEcCtD
Letrozole—Infestation—Docetaxel—head and neck cancer	0.00136	0.00326	CcSEcCtD
Letrozole—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00134	0.00321	CcSEcCtD
Letrozole—Myocardial infarction—Docetaxel—head and neck cancer	0.00133	0.0032	CcSEcCtD
Letrozole—Stomatitis—Docetaxel—head and neck cancer	0.00132	0.00318	CcSEcCtD
Letrozole—Body temperature increased—Hydroxyurea—head and neck cancer	0.00132	0.00316	CcSEcCtD
Letrozole—Leukopenia—Fluorouracil—head and neck cancer	0.00132	0.00316	CcSEcCtD
Letrozole—Asthenia—Vinblastine—head and neck cancer	0.00131	0.00315	CcSEcCtD
Letrozole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00128	0.00308	CcSEcCtD
Letrozole—Myalgia—Fluorouracil—head and neck cancer	0.00125	0.00301	CcSEcCtD
Letrozole—Chest pain—Fluorouracil—head and neck cancer	0.00125	0.00301	CcSEcCtD
Letrozole—Diarrhoea—Vinblastine—head and neck cancer	0.00125	0.003	CcSEcCtD
Letrozole—Discomfort—Fluorouracil—head and neck cancer	0.00124	0.00297	CcSEcCtD
Letrozole—Haemoglobin—Docetaxel—head and neck cancer	0.00122	0.00294	CcSEcCtD
Letrozole—Haemorrhage—Docetaxel—head and neck cancer	0.00122	0.00293	CcSEcCtD
Letrozole—Hepatitis—Docetaxel—head and neck cancer	0.00122	0.00293	CcSEcCtD
Letrozole—Hypoaesthesia—Docetaxel—head and neck cancer	0.00121	0.00291	CcSEcCtD
Letrozole—Dizziness—Vinblastine—head and neck cancer	0.00121	0.0029	CcSEcCtD
Letrozole—Urinary tract disorder—Docetaxel—head and neck cancer	0.0012	0.00289	CcSEcCtD
Letrozole—Oedema peripheral—Docetaxel—head and neck cancer	0.0012	0.00288	CcSEcCtD
Letrozole—Oedema—Fluorouracil—head and neck cancer	0.0012	0.00288	CcSEcCtD
Letrozole—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0012	0.00288	CcSEcCtD
Letrozole—Connective tissue disorder—Docetaxel—head and neck cancer	0.0012	0.00288	CcSEcCtD
Letrozole—Asthenia—Hydroxyurea—head and neck cancer	0.0012	0.00287	CcSEcCtD
Letrozole—Urethral disorder—Docetaxel—head and neck cancer	0.00119	0.00287	CcSEcCtD
Letrozole—Infection—Fluorouracil—head and neck cancer	0.00119	0.00286	CcSEcCtD
Letrozole—Nervous system disorder—Fluorouracil—head and neck cancer	0.00118	0.00283	CcSEcCtD
Letrozole—Tachycardia—Fluorouracil—head and neck cancer	0.00117	0.00281	CcSEcCtD
Letrozole—Vomiting—Vinblastine—head and neck cancer	0.00116	0.00279	CcSEcCtD
Letrozole—Erythema multiforme—Docetaxel—head and neck cancer	0.00115	0.00277	CcSEcCtD
Letrozole—Headache—Vinblastine—head and neck cancer	0.00114	0.00275	CcSEcCtD
Letrozole—Anorexia—Fluorouracil—head and neck cancer	0.00114	0.00275	CcSEcCtD
Letrozole—Diarrhoea—Hydroxyurea—head and neck cancer	0.00114	0.00274	CcSEcCtD
Letrozole—Eye disorder—Docetaxel—head and neck cancer	0.00114	0.00274	CcSEcCtD
Letrozole—Flushing—Docetaxel—head and neck cancer	0.00113	0.00272	CcSEcCtD
Letrozole—Cardiac disorder—Docetaxel—head and neck cancer	0.00113	0.00272	CcSEcCtD
Letrozole—Angiopathy—Docetaxel—head and neck cancer	0.00111	0.00266	CcSEcCtD
Letrozole—Dizziness—Hydroxyurea—head and neck cancer	0.0011	0.00265	CcSEcCtD
Letrozole—Mediastinal disorder—Docetaxel—head and neck cancer	0.0011	0.00264	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00109	0.00262	CcSEcCtD
Letrozole—Nausea—Vinblastine—head and neck cancer	0.00109	0.00261	CcSEcCtD
Letrozole—Insomnia—Fluorouracil—head and neck cancer	0.00108	0.00261	CcSEcCtD
Letrozole—Paraesthesia—Fluorouracil—head and neck cancer	0.00108	0.00259	CcSEcCtD
Letrozole—Alopecia—Docetaxel—head and neck cancer	0.00108	0.00259	CcSEcCtD
Letrozole—Dyspnoea—Fluorouracil—head and neck cancer	0.00107	0.00257	CcSEcCtD
Letrozole—Mental disorder—Docetaxel—head and neck cancer	0.00107	0.00256	CcSEcCtD
Letrozole—Somnolence—Fluorouracil—head and neck cancer	0.00107	0.00256	CcSEcCtD
Letrozole—Malnutrition—Docetaxel—head and neck cancer	0.00106	0.00255	CcSEcCtD
Letrozole—Vomiting—Hydroxyurea—head and neck cancer	0.00106	0.00254	CcSEcCtD
Letrozole—Dyspepsia—Fluorouracil—head and neck cancer	0.00106	0.00254	CcSEcCtD
Letrozole—Rash—Hydroxyurea—head and neck cancer	0.00105	0.00252	CcSEcCtD
Letrozole—Dermatitis—Hydroxyurea—head and neck cancer	0.00105	0.00252	CcSEcCtD
Letrozole—Headache—Hydroxyurea—head and neck cancer	0.00104	0.00251	CcSEcCtD
Letrozole—Decreased appetite—Fluorouracil—head and neck cancer	0.00104	0.0025	CcSEcCtD
Letrozole—Dysgeusia—Docetaxel—head and neck cancer	0.00104	0.00249	CcSEcCtD
Letrozole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00104	0.00249	CcSEcCtD
Letrozole—Back pain—Docetaxel—head and neck cancer	0.00103	0.00246	CcSEcCtD
Letrozole—Pain—Fluorouracil—head and neck cancer	0.00103	0.00246	CcSEcCtD
Letrozole—Nausea—Hydroxyurea—head and neck cancer	0.00099	0.00238	CcSEcCtD
Letrozole—Feeling abnormal—Fluorouracil—head and neck cancer	0.000988	0.00237	CcSEcCtD
Letrozole—Urticaria—Fluorouracil—head and neck cancer	0.000953	0.00229	CcSEcCtD
Letrozole—Leukopenia—Docetaxel—head and neck cancer	0.000949	0.00228	CcSEcCtD
Letrozole—Body temperature increased—Fluorouracil—head and neck cancer	0.000948	0.00228	CcSEcCtD
Letrozole—Palpitations—Docetaxel—head and neck cancer	0.000937	0.00225	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—AREG—head and neck cancer	0.000931	0.0772	CbGpPWpGaD
Letrozole—Cough—Docetaxel—head and neck cancer	0.000926	0.00222	CcSEcCtD
Letrozole—Hypertension—Docetaxel—head and neck cancer	0.000916	0.0022	CcSEcCtD
Letrozole—Arthralgia—Docetaxel—head and neck cancer	0.000903	0.00217	CcSEcCtD
Letrozole—Chest pain—Docetaxel—head and neck cancer	0.000903	0.00217	CcSEcCtD
Letrozole—Myalgia—Docetaxel—head and neck cancer	0.000903	0.00217	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000897	0.00215	CcSEcCtD
Letrozole—Dry mouth—Docetaxel—head and neck cancer	0.000883	0.00212	CcSEcCtD
Letrozole—Anaphylactic shock—Docetaxel—head and neck cancer	0.000866	0.00208	CcSEcCtD
Letrozole—Oedema—Docetaxel—head and neck cancer	0.000866	0.00208	CcSEcCtD
Letrozole—Infection—Docetaxel—head and neck cancer	0.00086	0.00207	CcSEcCtD
Letrozole—Nervous system disorder—Docetaxel—head and neck cancer	0.000849	0.00204	CcSEcCtD
Letrozole—Pruritus—Fluorouracil—head and neck cancer	0.000849	0.00204	CcSEcCtD
Letrozole—Tachycardia—Docetaxel—head and neck cancer	0.000845	0.00203	CcSEcCtD
Letrozole—Skin disorder—Docetaxel—head and neck cancer	0.000841	0.00202	CcSEcCtD
Letrozole—Anorexia—Docetaxel—head and neck cancer	0.000825	0.00198	CcSEcCtD
Letrozole—Diarrhoea—Fluorouracil—head and neck cancer	0.000821	0.00197	CcSEcCtD
Letrozole—CYP2A6—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.000794	0.0659	CbGpPWpGaD
Letrozole—Dizziness—Fluorouracil—head and neck cancer	0.000793	0.00191	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000789	0.00189	CcSEcCtD
Letrozole—Insomnia—Docetaxel—head and neck cancer	0.000783	0.00188	CcSEcCtD
Letrozole—Paraesthesia—Docetaxel—head and neck cancer	0.000777	0.00187	CcSEcCtD
Letrozole—Dyspnoea—Docetaxel—head and neck cancer	0.000772	0.00185	CcSEcCtD
Letrozole—Somnolence—Docetaxel—head and neck cancer	0.00077	0.00185	CcSEcCtD
Letrozole—Vomiting—Fluorouracil—head and neck cancer	0.000763	0.00183	CcSEcCtD
Letrozole—Dyspepsia—Docetaxel—head and neck cancer	0.000762	0.00183	CcSEcCtD
Letrozole—Rash—Fluorouracil—head and neck cancer	0.000756	0.00182	CcSEcCtD
Letrozole—Dermatitis—Fluorouracil—head and neck cancer	0.000755	0.00181	CcSEcCtD
Letrozole—Decreased appetite—Docetaxel—head and neck cancer	0.000752	0.00181	CcSEcCtD
Letrozole—Headache—Fluorouracil—head and neck cancer	0.000751	0.0018	CcSEcCtD
Letrozole—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000747	0.0018	CcSEcCtD
Letrozole—Fatigue—Docetaxel—head and neck cancer	0.000746	0.00179	CcSEcCtD
Letrozole—Constipation—Docetaxel—head and neck cancer	0.00074	0.00178	CcSEcCtD
Letrozole—Pain—Docetaxel—head and neck cancer	0.00074	0.00178	CcSEcCtD
Letrozole—Feeling abnormal—Docetaxel—head and neck cancer	0.000713	0.00171	CcSEcCtD
Letrozole—Nausea—Fluorouracil—head and neck cancer	0.000712	0.00171	CcSEcCtD
Letrozole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000708	0.0017	CcSEcCtD
Letrozole—Abdominal pain—Docetaxel—head and neck cancer	0.000684	0.00164	CcSEcCtD
Letrozole—Body temperature increased—Docetaxel—head and neck cancer	0.000684	0.00164	CcSEcCtD
Letrozole—Asthenia—Docetaxel—head and neck cancer	0.000621	0.00149	CcSEcCtD
Letrozole—Pruritus—Docetaxel—head and neck cancer	0.000612	0.00147	CcSEcCtD
Letrozole—Diarrhoea—Docetaxel—head and neck cancer	0.000592	0.00142	CcSEcCtD
Letrozole—Dizziness—Docetaxel—head and neck cancer	0.000572	0.00137	CcSEcCtD
Letrozole—Vomiting—Docetaxel—head and neck cancer	0.00055	0.00132	CcSEcCtD
Letrozole—Rash—Docetaxel—head and neck cancer	0.000546	0.00131	CcSEcCtD
Letrozole—Dermatitis—Docetaxel—head and neck cancer	0.000545	0.00131	CcSEcCtD
Letrozole—Headache—Docetaxel—head and neck cancer	0.000542	0.0013	CcSEcCtD
Letrozole—CYP2A6—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000528	0.0438	CbGpPWpGaD
Letrozole—Nausea—Docetaxel—head and neck cancer	0.000514	0.00124	CcSEcCtD
Letrozole—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000503	0.0417	CbGpPWpGaD
Letrozole—CYP2A6—Xenobiotics—CYP1A1—head and neck cancer	0.000421	0.0349	CbGpPWpGaD
Letrozole—CYP2A6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000405	0.0336	CbGpPWpGaD
Letrozole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000377	0.0312	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000376	0.0312	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000301	0.0249	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—head and neck cancer	0.000299	0.0248	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.000296	0.0245	CbGpPWpGaD
Letrozole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000292	0.0242	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000271	0.0225	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000236	0.0195	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00022	0.0182	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000217	0.018	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—NAT2—head and neck cancer	0.000202	0.0167	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—NAT2—head and neck cancer	0.000199	0.0165	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000197	0.0163	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.000186	0.0155	CbGpPWpGaD
Letrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000184	0.0153	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—MAPK3—head and neck cancer	0.000184	0.0153	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000178	0.0148	CbGpPWpGaD
Letrozole—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000177	0.0147	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—MAPK1—head and neck cancer	0.000175	0.0145	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000175	0.0145	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000172	0.0143	CbGpPWpGaD
Letrozole—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000168	0.0139	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.000161	0.0133	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.000156	0.0129	CbGpPWpGaD
Letrozole—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000154	0.0128	CbGpPWpGaD
Letrozole—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000148	0.0123	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000142	0.0117	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—AKT1—head and neck cancer	0.000124	0.0103	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	9.98e-05	0.00827	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTM1—head and neck cancer	9.97e-05	0.00827	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—GSTM1—head and neck cancer	9.83e-05	0.00815	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP1A1—head and neck cancer	9.45e-05	0.00784	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP1A1—head and neck cancer	9.32e-05	0.00773	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	9.05e-05	0.0075	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—UROD—head and neck cancer	8.31e-05	0.00689	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	7.94e-05	0.00658	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	7.92e-05	0.00657	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	7.65e-05	0.00635	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	7.56e-05	0.00627	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	7.52e-05	0.00624	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UROD—head and neck cancer	6.62e-05	0.00549	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	6.57e-05	0.00544	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.45e-05	0.00535	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	6.41e-05	0.00531	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	6.32e-05	0.00524	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—NAT2—head and neck cancer	5.89e-05	0.00488	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	5.81e-05	0.00482	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	5.64e-05	0.00467	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	5.44e-05	0.00451	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.19e-05	0.00431	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	4.91e-05	0.00407	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	4.42e-05	0.00367	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	4.42e-05	0.00367	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	3.71e-05	0.00308	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.67e-05	0.00304	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.63e-05	0.00301	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NAT2—head and neck cancer	3.45e-05	0.00286	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	3.14e-05	0.0026	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—DPYD—head and neck cancer	3.03e-05	0.00251	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.91e-05	0.00241	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—YAP1—head and neck cancer	2.87e-05	0.00238	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2.87e-05	0.00238	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.76e-05	0.00229	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NAT2—head and neck cancer	2.75e-05	0.00228	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	2.72e-05	0.00226	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UROD—head and neck cancer	2.43e-05	0.00201	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—DPYD—head and neck cancer	2.41e-05	0.002	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—YAP1—head and neck cancer	2.29e-05	0.0019	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.16e-05	0.00179	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.88e-05	0.00156	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TYMS—head and neck cancer	1.73e-05	0.00143	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTM1—head and neck cancer	1.71e-05	0.00141	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GPX1—head and neck cancer	1.63e-05	0.00135	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1A1—head and neck cancer	1.62e-05	0.00134	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TYMS—head and neck cancer	1.37e-05	0.00114	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM1—head and neck cancer	1.36e-05	0.00113	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.33e-05	0.0011	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPX1—head and neck cancer	1.3e-05	0.00108	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1A1—head and neck cancer	1.29e-05	0.00107	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NAT2—head and neck cancer	1.01e-05	0.000835	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—head and neck cancer	9.61e-06	0.000797	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—DPYD—head and neck cancer	8.83e-06	0.000733	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—YAP1—head and neck cancer	8.38e-06	0.000695	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTEN—head and neck cancer	8.38e-06	0.000695	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—head and neck cancer	7.65e-06	0.000634	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTEN—head and neck cancer	6.67e-06	0.000553	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CA—head and neck cancer	5.91e-06	0.00049	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TYMS—head and neck cancer	5.03e-06	0.000417	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.98e-06	0.000413	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—head and neck cancer	4.83e-06	0.000401	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPX1—head and neck cancer	4.77e-06	0.000395	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.72e-06	0.000391	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CA—head and neck cancer	4.71e-06	0.00039	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—head and neck cancer	3.85e-06	0.000319	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.81e-06	0.000233	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTEN—head and neck cancer	2.45e-06	0.000203	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.73e-06	0.000143	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—head and neck cancer	1.41e-06	0.000117	CbGpPWpGaD
